Zhongbing Qi

机构：Sichuan University, State Key Laboratory of Biotherapy · ORCID：0009-0003-4712-5097

发表论文 18 篇 · 总被引 347 次 · h-index 7

代表论文

• Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis (2021 · Acta Biomaterialia · 被引 199)
• Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy (2022 · Frontiers in Cellular Neuroscience · 被引 37)
• High-dose VitC plus oncolytic adenoviruses enhance immunogenic tumor cell death and reprogram tumor immune microenvironment (2021 · Molecular Therapy · 被引 29)
• The Effect of Residual Triton X-100 on Structural Stability and Infection Activity of Adenovirus Particles (2020 · Molecular Therapy — Methods & Clinical Development · 被引 16)
• Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity (2024 · Journal for ImmunoTherapy of Cancer · 被引 15)
• In Situ Tumor Vaccine Expressing Anti-CD47 Antibody Enhances Antitumor Immunity (2022 · Frontiers in Oncology · 被引 12)